Focus Partners Advisor Solutions’s GSK GSK Stock Holding History

Focus Partners Advisor Solutions’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$411K	Buy	7,840 +379	+5%	+$20K	﹤0.01%	878
2026 Q1	$412K	Buy	7,461 +1,173	+19%	+$63.6K	﹤0.01%	860
2025 Q4	$308K	Sell	6,288 -146	-2%	-$6.81K	﹤0.01%	878
2025 Q3	$291K	Buy	6,434 +369	+6%	+$14.4K	﹤0.01%	920
2025 Q2	$233K	Buy	+6,065	New	+$232K	﹤0.01%	967

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Focus Partners Advisor Solutions's GSK Position: Q2 2026 in Review

Focus Partners Advisor Solutions increased its GSK (GSK) stake by 5.1% in Q2 2026, buying an estimated $20K and bringing the position to 7,840 shares worth $411K. The position accounts for ﹤0.01% of the portfolio, ranked #878.

Focus Partners Advisor Solutions first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. The position peaked at $412K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Focus Partners Advisor Solutions held 7,840 shares of GSK worth $411K as of Q2 2026.
Focus Partners Advisor Solutions bought 379 GSK shares in Q2 2026, an estimated $20K.
GSK made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #878 holding.
Focus Partners Advisor Solutions first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
Focus Partners Advisor Solutions's GSK position peaked at $412K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.